Feb 4, 2016 7:00 am EST VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection
Feb 2, 2016 7:00 am EST VolitionRx Initiates Prostate Cancer Study in Collaboration with the Surrey Cancer Research Institute, University of Surrey, UK
Jan 28, 2016 7:00 am EST VolitionRx Receives International ISO Certification for Quality Management System of its NuQ(R) Blood Tests
Jan 5, 2016 7:00 am EST VolitionRx Announces Dr. Jason Terrell's Transition to Full-Time Status as Chief Medical Officer and Head of U.S. Operations
Dec 8, 2015 7:00 am EST VolitionRx Demonstrates More Than 90% Accuracy for Colorectal Cancer NuQ(R) Blood Test in Completed Prospective Study
Nov 19, 2015 7:00 am EST VolitionRx Demonstrates NuQ® Blood Test Detects Lung Cancers with more than 90% Accuracy
